What's breaking now, across thousands of outlets.
(MedPage Today) -- Orforglipron (Foundayo) was able to claim cardiovascular safety based on the ACHIEVE-4 trial, though heart benefits remain unproven. Among adults with type 2 diabetes and obesity or overweight at risk for increased cardiovascular...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Teens whose sleep length swings from night to night report more anxiety and sadness, a Fitbit-based study of 1,371 adolescents finds.
Researchers from the University of Bath have developed fluorescent molecular probes that can detect changes in glucose levels inside living animals, giving scientists new ways of visualizing sugar…
Pennsylvania health officials reported a fifth measles-associated death Wednesday amid a rapidly growing outbreak that’s the worst the commonwealth has seen in over 35 years.
The Centers for Medicare and Medicaid Services finalized a demonstration program aimed at lowering the prices of drugs in Medicare, but with significantly lower expected savings than previously…
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct.
